Novogaia
Supplier
Summarized by Halo AI
Novogaia develops “Gaia-01/02”, foundation models that predict molecular structures directly from mass spectrometry data to support early drug-discovery workflows.
Portfolio summary
Pioneering drug discovery by decoding fungal chemistry to uncover new bioactive small molecules using machine learning, fungal genomics, and mass spectrometry
Markets served
NA · EMEA
Novogaia is a biotech company specializing in applying machine learning to natural product discovery, particularly from fungi, to develop new therapeutics.
AI summary generated on Jun 22, 2026
OpenAlex
OpenAlexFor general inquiries
TB
Tess Bevers
CEO
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.